Trademark: 98113173
Word
TYZAVAN
Status
Pending
Status Code
686
Status Date
Tuesday, May 14, 2024
Serial Number
98113173
Mark Type
4
Filing Date
Wednesday, August 2, 2023
Published for Opposition
Tuesday, May 14, 2024
Trademark Owner History
Xellia Pharmaceuticals ApS - Owner At Publication
Classifications
5 Anti-infective, injectable pharmaceutical products in liquid finished dosage form for use in hospitals and clinics or by home health care professionals
The wording "TYZAVAN" has no meaning in a foreign language.
Trademark Events
Aug 5, 2023
New Application Entered
Aug 7, 2023
New Application Office Supplied Data Entered
Jan 5, 2024
Teas Voluntary Amendment Received
Jan 5, 2024
Teas Amendment Entered Before Attorney Assigned
Apr 3, 2024
Assigned To Examiner
Apr 4, 2024
Examiners Amendment -Written
Apr 4, 2024
Examiners Amendment E-Mailed
Apr 4, 2024
Notification Of Examiners Amendment E-Mailed
Apr 4, 2024
Examiner's Amendment Entered
Apr 4, 2024
Approved For Pub - Principal Register
Apr 24, 2024
Notification Of Notice Of Publication E-Mailed
May 14, 2024
Published For Opposition
May 14, 2024
Official Gazette Publication Confirmation E-Mailed
WILDE CARDS
CONSCIOUSLY MINDED
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - GRJR PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov